Skip to content
Next Edition

The Zimbabwean Government Rejects ‘One-Sided’ American Healthcare Assistance Package Over Information Fears

Health funding illustration
The offered American financial assistance was intended for initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a significant US health deal worth 367 million US dollars (£272m) spanning five years because of Washington's request for confidential information.

This move was revealed following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".

An official representative later stated that the US was seeking health data for research and profit while was not willing to guarantee the resulting advantages from future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged further dialogue to find a deal agreeable to both sides so the country's vital HIV programme can continue.

Broader Context

This development follows a similar case in neighbouring Kenya, where a court halted a related deal with the US after concerns were filed about the safety of Kenyans' health data.

Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and accountability.

As per reports, Sixteen nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Agreement

The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.

"Effectively, our country would provide the raw materials for medical research with no certainty that the end products would be accessible to our population if a new pandemic emerge."

National Interest and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its push of one-on-one deals were upending frameworks already set up via the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing system created to deal with future global health emergencies.

"This system is intended to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."

These objections over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome further dialogue with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the independence and dignity of both nations."

Health Experts Reaction

A leading public health body stated it acknowledged the government's concerns, but recommended that negotiations need to persist given that a large portion of the nation's Aids initiatives relied on international support.

"If technical issues arise, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.

The situation emphasises the ongoing challenges between accepting crucial foreign assistance and protecting local interests in an ever more data-driven world.

The writer

Kevin Thompson

Maya is a tech journalist with over a decade of experience covering emerging technologies and digital trends.

Next Edition

Type to search articles.